CASRAI Dictionary

Tag: retraction watch

  • Famous Cases of Research Misconduct in India: Building Investigation Capacity

    India has produced a long run of documented research misconduct cases — plagiarism by university vice-chancellors, data manipulation at premier institutes, and mass retractions from the Indian Institutes of Technology (IITs) — because the country has no statutory equivalent of the US Office of Research Integrity. Since 2018, that gap has started closing through UGC regulations, an ICMR ethics policy, and India’s first dedicated Research Integrity Office, opened in Bengaluru in 2022.

    Research misconduct is the fabrication, falsification, or plagiarism of data or authorship in proposing, performing, or reviewing research, or in reporting research results. In India, the term also commonly extends to duplicate (“self-plagiarism”) publication and fraudulent peer review, both of which feature heavily in the country’s retraction record.

    This article sets out the famous cases of research misconduct in india that shaped public and regulatory attention, then examines — in more depth than the case lists alone provide — the specific institutional mechanisms India has built since 2018 to investigate and deter misconduct, benchmarked against the UK’s comparable framework.

    What is research misconduct, and how common is it in India?

    Research misconduct covers fabrication, falsification, plagiarism, and — in India’s documented record — duplicate publication and compromised peer review. India does not operate a statutory oversight body comparable to the US Office of Research Integrity, so cases are typically investigated on an ad-hoc basis by institutional committees, independent enquiry panels, or journal editors, often only after a public complaint or media report triggers action.

    Retraction volume gives a rough proxy for scale. An analysis by the volunteer watchdog Indian Research Watch (IRW), drawing on the Retraction Watch database, found that 58 papers authored or co-authored by faculty across 12 of India’s 23 IITs were retracted for plagiarism or duplicate publication between 2006 and 2023 — compared with three retractions from Stanford, two from Princeton, five from Oxford, five from Cambridge, and ten from Tsinghua over the same period. IRW also recorded a 2.5-fold surge in Indian institutional retractions in 2020–2022 compared with 2017–2019.

    Which cases shaped India’s research misconduct record?

    A handful of cases became reference points for how India investigates — and fails to investigate — misconduct allegations.

    • B.S. Rajput, Kumaon University (2002–2003): the vice-chancellor was accused by Indian and international physicists, including a Nobel laureate co-signatory, of plagiarising a paper from a Stanford researcher. A committee led by retired judge Justice S.R. Singh upheld the charge in February 2003, and Rajput resigned immediately.
    • Gopal Kundu, National Centre for Cell Science, Pune (2006–2010): an anonymous complaint alleged data misrepresentation in a Journal of Biological Chemistry paper. The journal withdrew the paper in 2007, and the Indian Academy of Sciences barred Kundu from its activities for three years following an internal ethics review in 2010.
    • Ashok Kumar, IIT Kanpur (2010): two review articles in Biotechnology Advances were retracted for extensive copying, prompting the Society for Scientific Values to publicly reprimand several IITs over lax plagiarism handling that year.
    • P. Chiranjeevi, Sri Venkateswara University (2004–2008): a chemistry professor was found to have plagiarised content across roughly 70 papers; the university barred him from examination duties, research guidance, and further promotion.
    • Sanjeeb Kumar Sahoo, Institute of Life Sciences, Bhubaneswar (2013): five papers in Acta Biomaterialia were retracted for serial self-plagiarism, data manipulation, and falsification of results.

    These cases share a pattern: detection came from external whistleblowers, journal editors, or watchdog groups rather than routine institutional audit — the exact gap India’s newer capacity-building measures target.

    How are Indian institutions building investigation capacity?

    Since 2018, national regulators and individual institutions have begun replacing ad-hoc responses with defined procedures, though implementation remains uneven across India’s roughly 1,000-plus universities.

    • UGC (Promotion of Academic Integrity and Prevention of Plagiarism in Higher Educational Institutions) Regulations, 2018: the University Grants Commission’s regulation defines plagiarism thresholds by similarity-index band and prescribes tiered penalties, from reworking a manuscript to debarment from supervising research.
    • Mandatory Research and Publication Ethics (RPE) training: UGC rules require a two-credit RPE course for all PhD scholars, intended to instil ethical practice before misconduct occurs rather than only punishing it afterward.
    • UGC-CARE (Consortium for Academic and Research Ethics): maintains a vetted journal list to steer researchers away from predatory publications that facilitate low-scrutiny misconduct.
    • ICMR research integrity policy: the Indian Council of Medical Research has its own publication-ethics and research-integrity policy governing biomedical research, alongside its National Ethical Guidelines for Biomedical and Health Research.
    • India’s first dedicated Research Integrity Office: in 2022, the Institute for Stem Cell Science and Regenerative Medicine (inStem) and the National Centre for Biological Sciences (NCBS) in Bengaluru jointly established India’s first standing Research Integrity Office, tasked with policy-setting, data archiving, training, and case investigation — a structural model still rare outside this campus.
    • Independent watchdogs: the Society for Scientific Values, active since the 1980s, and Indian Research Watch, founded in 2022 by data scientist Achal Agrawal, continue to supply the external scrutiny that formal bodies have not yet fully absorbed.

    How does India’s framework compare with the UK’s?

    The UK’s research misconduct architecture is older and more codified, offering a useful benchmark for what a mature system looks like once statutory pressure and funder mandates are added.

    Feature India United Kingdom
    Core guidance document UGC 2018 Regulations; ICMR research integrity policy Universities UK Concordat to Support Research Integrity (2019 revision)
    Statutory oversight body None — no equivalent to the US Office of Research Integrity None — UK Research Integrity Office (UKRIO) is advisory, not statutory
    Institutional requirement Ethics/misconduct committees, variably implemented Named research integrity lead plus an annual public statement to funders
    Investigation trigger Usually a whistleblower complaint or media report Defined internal procedure for the investigation of misconduct in research, often COPE-aligned, with escalation routes to funders

    The comparison shows India’s 2018–2022 reforms following a similar path the UK walked earlier — moving from voluntary good practice toward named responsibility and funder-linked reporting — but roughly a decade behind in institutional coverage.

    Frequently asked questions

    What are some examples of research misconduct?

    Fabrication, falsification, and plagiarism are the three core categories recognised internationally. In India’s record, this has manifested as copied text and images, manipulated western blot data, duplicate (“self-plagiarised”) publication, and fraudulent peer review used to fast-track weak manuscripts into print.

    What are the 5 unethical practices in research?

    The five widely cited categories are falsification of data, failure to credit others, plagiarism, conflicts of interest, and biased design or interpretation driven by outside influence. Indian cases documented above illustrate the first three most frequently, particularly plagiarism and data falsification.

    What are the implications for institutions, publishers, and funders?

    For Indian institutions, the direction is toward standing capacity rather than reactive committees: named integrity offices, mandatory ethics training, and journal-quality filtering via UGC-CARE. For international publishers and funders working with Indian co-authors, the retraction data signal a need for stronger pre-publication screening rather than reliance on post-hoc whistleblowing. For research administrators globally, India’s experience underscores a broader lesson also visible in research administration practice elsewhere: investigation procedures only function once an institution has a named owner, a documented process, and independence from the department under review.

    Conclusion: the road ahead

    India’s famous research misconduct cases exposed a structural gap: no statutory body, uneven institutional follow-through, and detection driven mostly by outsiders. The 2018 UGC regulations, ICMR’s integrity policy, mandatory RPE training, and the 2022 inStem/NCBS Research Integrity Office mark a genuine shift toward standing investigation capacity. Whether that capacity scales beyond a handful of leading institutions to India’s broader university system remains the open question for the next decade.

  • Elsevier’s Research Integrity Screening Process

    Elsevier screens research submissions for integrity issues through a layered pipeline: automated tools such as Check Integrity and Crossref Similarity Check flag plagiarism, duplicate submissions and image anomalies at intake, specialist Research Integrity and Publishing Ethics (RIPE) analysts investigate confirmed concerns, and outcomes range from correction through expression of concern to full retraction, following guidelines set by the Committee on Publication Ethics (COPE).

    Research integrity screening is the set of technical checks and human review stages a publisher applies to a manuscript, before and after publication, to detect fabrication, falsification, plagiarism, undisclosed image manipulation and paper-mill activity. At Elsevier, that pipeline runs continuously from the moment a manuscript is submitted to the point, if necessary, of retraction.

    How Elsevier’s research-integrity pipeline works, from submission to retraction

    Elsevier operates one of the largest editorial screening operations in scholarly publishing. In 2025, the publisher received 4.2 million manuscript submissions across roughly 3,000 journals and published 795,000 after validation and peer review, according to Elsevier’s own account of its editorial process. Elsevier states that its published output accounts for over 18% of global research output and 29% of citations — a scale that shapes why it has invested heavily in both automated screening and dedicated integrity staff rather than relying on peer review alone.

    The pipeline runs across four broad stages, each with a different primary tool or team responsible for catching a different class of problem.

    Stage Primary tool or team Typical trigger
    Submission intake Check Integrity screening tool; Crossref Similarity Check (iThenticate) Text overlap, duplicate manuscript, unauthorised authorship change
    Peer review Editors, external reviewers, RIPE analysts Implausible data, reviewer-flagged inconsistency, suspicious image reuse
    Post-publication monitoring Research Integrity and Publishing Ethics (RIPE) team Reader or whistleblower reports, cross-journal pattern analysis
    Enforcement Editors-in-chief, following COPE-guided process Confirmed fabrication, falsification or plagiarism

    What does Elsevier screen for at the point of submission?

    Every manuscript submitted to an Elsevier journal is routed through automated checks before an editor sees it. Check Integrity, Elsevier’s proprietary screening tool, had been expanded across more than 2,000 journals as of March 2026, according to trade press coverage in Research Information. The tool automatically reviews submissions for red flags — including unauthorised authorship changes, undisclosed conflicts of interest and signs of duplicate or template-like submission — and routes anything flagged to specialist integrity analysts, freeing editors to focus on scientific merit.

    Plagiarism screening runs in parallel through Crossref Similarity Check, powered by iThenticate, which compares submitted text against a large index of published articles and web content. There is no fixed similarity percentage that automatically triggers rejection; editors interpret each report to distinguish appropriate citation from genuine textual misconduct.

    Paper-mill detection layers on top of these checks. Integrity analysts look for patterns that recur across industrialised fraud, including:

    • Formulaic, template-like titles or methods sections
    • Unusual or inconsistent author affiliations and contact details
    • Data or experimental descriptions that do not match the stated methodology
    • Systematic image reuse across ostensibly unrelated papers
    • Irregular peer-review patterns, such as reviewer suggestions tied to the same small pool of contacts

    How does Elsevier detect image manipulation and data-integrity problems?

    Image screening combines editorial guidelines with a mix of manual and software-assisted checks. Elsevier’s policy permits minor adjustments to brightness, contrast or colour balance only where they do not obscure or eliminate information present in the original image; the use of generative AI to create or alter a figure is prohibited outright. Where manipulation is suspected, editors can apply forensic image-analysis tools of the kind recommended by the US Office of Research Integrity, and will typically request the original, unprocessed image files directly from the authors.

    Elsevier has also published on the scale of automated flagging behind these checks. At the 8th World Conference on Research Integrity in 2024, Elsevier data scientist Yuri Kashnitsky presented on large-scale flagging of integrity misconduct across the publisher’s portfolio, noting that all system-generated findings are manually checked and confirmed by investigators before any corrective action is suggested to editors — underscoring that software narrows the search space, but a human analyst still makes the determination.

    Who investigates confirmed misconduct, and what enforcement follows?

    Once a concern is substantiated, Elsevier’s in-house Research Integrity and Publishing Ethics (RIPE) team leads the investigation, working with journal editors and, where warranted, the authors’ institutions. Elsevier states that it follows retraction guidelines developed by COPE, and confirmed problems resolve into one of three outcomes: a correction or erratum for errors that do not undermine the paper’s conclusions, an expression of concern where the investigation is inconclusive but doubts remain, or a retraction where the findings are no longer considered reliable.

    A recent case shows this enforcement ladder operating at scale. In a statement updated in May 2026, Elsevier disclosed that a comprehensive, multi-year audit of the journal Heliyon — using Check Integrity screening combined with manual review by RIPE analysts — had produced approximately 1,100 corrections to the scientific record, affecting around 3% of everything the journal had published across 12 years. Those 1,100 actions spanned corrections, expressions of concern and retractions; impacted authors were notified and given the chance to respond before editors made a final determination. Following the audit, Web of Science removed an indexing hold it had placed on Heliyon, and Elsevier said it was applying lessons from the case to workflows across its wider journal portfolio.

    Common questions about Elsevier’s integrity screening

    Does Elsevier use iThenticate for plagiarism screening?

    Yes. Elsevier’s journals route submitted manuscripts through Crossref Similarity Check, which is powered by iThenticate, comparing text against a large index of published articles and web content. Editors, not the software alone, judge whether flagged overlap reflects proper citation or genuine plagiarism before any editorial decision is made.

    Who investigates allegations of research misconduct at Elsevier?

    Elsevier’s in-house Research Integrity and Publishing Ethics (RIPE) team investigates confirmed concerns, working alongside journal editors and, where relevant, the authors’ institutions. Investigations follow COPE guidelines and typically involve requesting raw underlying data before any corrective action is taken.

    What is considered the most serious form of research misconduct?

    Fabrication and falsification of data are generally treated as the most serious forms of misconduct, alongside plagiarism, because they directly corrupt the reliability of the published record. Elsevier’s policies place these above lesser breaches such as citation gaming or unresolved authorship disputes.

    What happens after a research-integrity investigation confirms a problem?

    Confirmed issues lead to one of three outcomes: a correction for errors that do not undermine the findings, an expression of concern where evidence is inconclusive, or a retraction where the results are no longer considered reliable. All three are published and linked to the original article, per COPE guidance.

    What this means for institutions, authors and integrity offices

    For research administrators, the Heliyon case is a reminder that publisher-side screening is a complement to institutional processes, not a substitute for them. When a journal’s RIPE team contacts an institution about a flagged submission or published paper, that request typically triggers — and depends on — the institution’s own research-integrity office and record-keeping, an area covered in more detail in CASRAI’s research administration resources and its wider research-integrity dictionary entries. Authors, in turn, should expect to be asked for raw, unprocessed data or images at any stage, including years after publication, and should retain those records accordingly.

    Elsevier is not acting alone: it collaborates with other publishers through the STM Integrity Hub to detect duplicate submissions across the wider industry, reflecting a broader shift toward cross-publisher, not just single-journal, integrity infrastructure. As automated screening tools mature, the balance is likely to keep shifting toward earlier detection at submission — but the Heliyon audit shows that human RIPE analysts, not algorithms, remain the ones who make the final call on correction, expression of concern or retraction.

  • Famous Research Misconduct Cases in Psychology: Why the Field Faces Unique Scrutiny

    The famous cases of research misconduct in psychology — Diederik Stapel, Marc Hauser, Karen Ruggiero and Brian Wansink — span outright data fabrication to borderline questionable research practices (QRPs), and together they exposed a discipline whose statistical culture made both fraud and self-deception unusually easy to commit and unusually slow to catch. Research misconduct is formally defined as fabrication, falsification or plagiarism (FFP) in proposing, performing or reviewing research, or in reporting results; psychology’s unique exposure came from a perfect storm of small samples, flexible statistics and a “publish or perish” incentive structure that the field’s own 2010s replication crisis later laid bare.

    Unlike biomedical fraud, which usually involves a single fabricated dataset, psychology’s misconduct scandals repeatedly intersected with a discipline-wide reproducibility problem — meaning some of its “famous cases” are proven fraud, while others are unproven QRPs that were only distinguishable from fraud after the field built better detection tools.

    What is research misconduct in psychology?

    Research misconduct is fabrication, falsification, or plagiarism in proposing, conducting, reviewing, or reporting research — the “FFP” definition used by the US Office of Research Integrity and mirrored in the UK’s Concordat to Support Research Integrity. Psychology cases fall into this definition unevenly: some, like data fabrication, are unambiguous; others involve practices that were once normalised and only later reclassified as unacceptable.

    This matters because psychology’s most cited scandals are not a single category. Some researchers invented entire datasets from nothing. Others manipulated real data through selective analysis choices that fell short of formal fabrication but still produced unreliable findings. Distinguishing the two is essential to understanding why the field’s scrutiny has been so intense and so prolonged.

    Which cases define psychology’s misconduct history?

    Four cases anchor most discussions of research misconduct in psychology. Each was detected differently, and each shaped a different part of the field’s subsequent reform.

    • Diederik Stapel (Tilburg University, social psychology): admitted in 2011 to fabricating or manipulating data across dozens of studies, ultimately resulting in 58 retractions — the largest fabrication case in the field’s history, uncovered after junior colleagues reported inconsistencies in datasets that appeared too clean to be real.
    • Marc Hauser (Harvard University, cognitive science): found responsible for eight counts of scientific misconduct by a Harvard investigation in 2010, involving fabricated and falsified data on primate cognition; he resigned in 2011 after a paper in Cognition was retracted.
    • Karen Ruggiero (Harvard University, social psychology): admitted to fabricating data in five discrimination-related experiments; failed replication attempts triggered the discovery, and in 2001 the US Public Health Service imposed a five-year federal funding ban.
    • Brian Wansink (Cornell Food and Brand Lab): a 2018 Cornell investigation found no evidence of data fabrication but confirmed misreported data, flawed statistics, and inappropriate authorship practices; six of his papers were retracted by JAMA network journals on a single day in September 2018, part of an eventual total exceeding a dozen retractions.

    The Wansink case is the pivot point for understanding why psychology’s scrutiny differs from other fields: it was not fraud in the FFP sense, yet it did more to popularise the term “questionable research practices” than any fabrication case before it.

    Why did the replication crisis intersect so heavily with misconduct?

    Psychology’s misconduct scandals broke at almost the same moment as its reproducibility crisis, and the two fed each other. The Open Science Collaboration’s 2015 Reproducibility Project, published in Science, attempted to replicate 100 published psychology studies and found that only around 36% produced statistically significant results matching the original direction — a figure that made the entire discipline’s evidentiary base look fragile, not just the work of a few fraudsters.

    That fragility had identifiable causes that predate any individual scandal:

    • Small sample sizes increased the odds that a false-positive result would look statistically significant and be published.
    • P-hacking — running multiple analyses until one crosses the p<0.05 threshold — was shown by Simmons, Nelson and Simonsohn’s influential 2011 “false-positive psychology” paper to make almost any hypothesis appear supported.
    • HARKing (hypothesising after results are known) let researchers present exploratory findings as if they had been predicted in advance.
    • Publication bias rewarded novel, positive results and left null findings in the file drawer, distorting the published record even without any individual acting in bad faith.

    Daryl Bem’s 2011 “Feeling the Future” precognition study, published in the Journal of Personality and Social Psychology using entirely conventional statistical methods, is often cited as the moment the field realised its standard toolkit could produce an implausible result — arriving in the same period Stapel’s fraud was exposed. The coincidence of timing meant fabrication and questionable-but-legal statistics were investigated side by side, and the public struggled to separate the two.

    Fabrication vs questionable research practices: where is the line?

    The distinction between outright fabrication and QRPs is the single most misunderstood part of psychology’s misconduct history, and it explains why some “famous cases” ended careers while others prompted only policy reform.

    Case Confirmed misconduct type Detection method Institutional outcome
    Diederik Stapel Fabrication (FFP) Colleague-reported data inconsistencies 58 retractions; resigned 2011
    Marc Hauser Fabrication/falsification (FFP) Internal Harvard investigation 8 misconduct counts; resigned 2011
    Karen Ruggiero Fabrication (FFP) Failed independent replication 5-year federal funding ban (2001)
    Brian Wansink Questionable research practices, not FFP Journalist and blogger scrutiny of published p-values 13+ retractions; resigned 2018

    The Stapel, Hauser and Ruggiero cases were confirmed FFP violations following formal investigations. Wansink’s case is different in kind: Cornell’s inquiry explicitly did not find fabricated data, yet the scale of statistical and reporting problems was severe enough to end his career and trigger a wave of scrutiny of “p-hacked” nutrition and consumer-behaviour research across the field.

    Common questions about psychology’s misconduct cases

    What are some examples of research misconduct?

    Research misconduct includes fabrication (inventing data), falsification (altering real data or results), and plagiarism. In psychology, documented examples include Diederik Stapel’s fabricated datasets across 58 retracted papers and Karen Ruggiero’s invented discrimination-study data, both confirmed by formal institutional investigations.

    What are the five unethical practices most associated with research misconduct?

    Commonly cited unethical practices are fabrication of data, failure to credit others, plagiarism, undisclosed conflicts of interest, and biased design or interpretation. Psychology’s scandals add a sixth practical concern: undisclosed post hoc statistical manipulation, which sits just outside formal misconduct definitions but produces comparably unreliable findings.

    Is the “most famous case study in psychology” the same as a misconduct case?

    No — famous case studies (Little Albert, the Stanford Prison Experiment) are ethically debated research designs, not confirmed fraud. Misconduct cases like Stapel’s involve proven fabricated data, whereas case-study controversies typically involve consent, coercion, or methodological criticism rather than invented results.

    What changed, and what it means for research integrity now

    Psychology’s response to its misconduct-and-replication double crisis has been more structural than punitive. The Center for Open Science’s Transparency and Openness Promotion (TOP) Guidelines, introduced in 2015, have been adopted by more than 1,000 journals and push researchers toward preregistration, open data, and open materials as standard practice rather than optional virtue.

    For research administrators and institutions, the practical lesson is attribution, not just detection. Multi-author fabrication cases are hard to unwind precisely because it is often unclear who ran the analysis, who collected the data, and who wrote the manuscript. Structured contributor taxonomies such as the CRediT contributor role taxonomy — originated by CASRAI in 2014 and now stewarded by NISO as ANSI/NISO Z39.104-2022 — give institutions a documented record of who performed formal analysis, data curation, and investigation roles on a paper, which is exactly the information gap that slowed the Stapel and Hauser investigations.

    Psychology’s misconduct history is not over, but it is better instrumented than it was in 2011. Preregistration, statistical detection tools, and clearer contributor accountability mean the next fabrication case is more likely to be caught earlier — and more likely to be correctly distinguished from a legitimate but flawed questionable research practice.

  • Publication Misconduct in Research: The Post-Publication Process

    Publication misconduct in research discovered after a paper is already public triggers a defined post-publication pipeline: a reader or institution files a complaint, the journal opens a formal investigation guided by COPE, an expression of concern may be issued while it runs, and a retraction or correction follows if misconduct is confirmed.

    Publication misconduct is unethical conduct in the publishing process itself — fabrication, falsification, plagiarism, duplicate submission, or fraudulent (ghost, guest or gift) authorship — as distinct from poor research design or an honest error in the underlying study. Once a flawed paper has already been indexed, cited and built upon, the mechanics of fixing the record are entirely different from catching the same problem at peer review. This article sets out what actually happens once that process starts, who runs it, and how the outcome gets communicated to readers and indexers.

    What counts as publication misconduct once a paper is already public?

    Publication misconduct covers conduct in the writing and submission of a paper, not the underlying experiment: fabrication (inventing data), falsification (manipulating images, figures or results), plagiarism, duplicate or redundant publication, and fraudulent authorship such as ghost, guest or gift authorship. The Royal Society’s publishing ethics policy defines research misconduct as “fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results” — and explicitly excludes “honest error or differences of opinion” from that definition.

    That exclusion matters at the post-publication stage. An editor’s first job on receiving a complaint is not to assume guilt but to classify the report: is this a correctable mistake, an authorship dispute, or a potential integrity breach that needs a formal case? Only the third category enters the investigation pipeline described below.

    What triggers a post-publication review?

    Post-publication scrutiny rarely originates with the journal itself. It is most often triggered externally, then formalised internally once a case is opened.

    • Reader or third-party complaints — direct emails to the editor, or public flags on post-publication review platforms such as PubPeer.
    • Institutional referral — a university research integrity office notifies the journal after its own internal inquiry.
    • Journal screening tools — image-manipulation and paper-mill detection software run against submitted or already-published figures.
    • Whistleblowers — co-authors, former colleagues or lab members raising concerns directly.
    • Funder or sponsor notice — a grant body flags a discrepancy found during its own audit.

    Under the ICMJE Recommendations, editors who receive “convincing evidence” of misconduct have a duty to pursue the matter — including by contacting the authors’ institution — rather than simply declining to act on an anonymous tip.

    How does the editorial investigation actually run?

    Once a case is opened, the journal follows a sequence set out in COPE’s guidance rather than improvising case by case. The Committee on Publication Ethics (COPE) Retraction Guidelines (2019) and its accompanying flowcharts are the reference most editors use to decide what to do next, and in what order.

    1. Initial screening — the editor checks whether the complaint is plausible and falls within the journal’s remit.
    2. Author response — the corresponding author is asked to explain, and usually to supply raw data, original images or lab records.
    3. Institutional referral — if the explanation is unsatisfactory or the allegation is serious, the editor notifies the authors’ institution, which runs its own inquiry under its research integrity policy; the journal does not adjudicate misconduct itself.
    4. Interim notice — while the inquiry is unresolved, the journal may publish an editorial expression of concern attached to the paper.
    5. Final notice — depending on the outcome, the journal publishes a correction, a retraction, or lifts the expression of concern with no further action.

    This sequencing is the core distinction between research-stage and publication-stage misconduct handling: at the research stage, a funder or institution can simply stop a study; at the publication stage, the journal must communicate every step publicly, because the paper is already part of the citable literature.

    Retraction, correction, or expression of concern — what is the difference?

    These three notice types are not interchangeable, and mixing them up is one of the most common errors in coverage of publication misconduct. Each has a distinct trigger, a distinct effect on the paper’s citability, and a distinct authority that can issue it.

    Notice type When it is issued Effect on the paper Who can issue it
    Correction / erratum / corrigendum An error is confirmed but conclusions still hold Paper stands; correction is linked to it Editor, with author agreement
    Editorial expression of concern Investigation is open but unresolved Paper stands but is flagged as unreliable pending outcome Editor, independently of authors
    Retraction Misconduct or unreliable findings confirmed Paper is marked “RETRACTED” but remains accessible for transparency Editor, authors, or institution

    A retracted paper is not deleted. Standard practice, reflected in NISO RP-45-2022, Communication of Retractions, Removals, and Expressions of Concern (CREC), requires the original text to remain online with a clear, permanent watermark and a linked retraction notice explaining the reason — so the scientific record stays transparent rather than simply erased. Since 2023, Crossref has hosted the freely available Retraction Watch Database, giving publishers, institutions and reference managers a shared, machine-readable source of retraction metadata rather than relying on scattered publisher notices alone.

    Common questions about post-publication misconduct

    What is the difference between a retraction, a correction, and an expression of concern?

    A correction fixes a confirmed error while the paper’s conclusions stand. An expression of concern flags an unresolved investigation without prejudging guilt. A retraction is issued once misconduct or unreliable findings are confirmed, permanently marking the paper as withdrawn from the reliable literature while keeping it accessible.

    What triggers a post-publication misconduct investigation?

    Investigations are usually triggered by a reader complaint, a post-publication review platform flag, an institutional referral, a whistleblower report, or automated screening for image manipulation or paper-mill patterns. Under the ICMJE Recommendations, editors receiving credible evidence have a duty to pursue it rather than dismiss it.

    Does a retracted paper disappear from the internet?

    No. Under NISO’s CREC recommended practice, retracted articles must remain accessible with a permanent watermark and a linked retraction notice. Removal is reserved for rare cases involving legal risk, such as defamation or serious safety hazards, not ordinary misconduct findings.

    Who decides whether a published paper is retracted?

    The journal editor makes the final call, but the decision is informed by the authors’ institution, which runs the substantive misconduct inquiry. COPE’s Retraction Guidelines position the journal as the notice-issuing authority and the institution as the fact-finding authority — the two roles are kept deliberately separate.

    What does this mean for institutions and authors?

    For research administrators, a post-publication complaint is not a journal-only event. Institutions are expected to run a parallel inquiry, respond to editor requests for data within a defined timeframe, and — if misconduct is confirmed — cooperate on the retraction notice’s wording under COPE guidance. Authors named on a retracted paper should expect it to be discoverable through Crossref’s Retraction Watch Database and CrossMark update badges wherever it is cited or indexed, regardless of original host.

    Contributor-role clarity also matters here: disputes over who is accountable for which part of a paper are easier to resolve when contributions were recorded precisely at submission. CASRAI’s authorship resources and research administration guidance cover structuring that accountability before a dispute reaches an editor’s desk.

    Where the retraction pipeline is heading

    Two shifts are changing post-publication misconduct handling. First, machine-readable retraction metadata — now centralised at Crossref rather than scattered across publisher sites — propagates a retraction to citation databases and discovery layers automatically, closing a gap that once left retracted papers silently cited for years. Second, paper-mill detection is shifting discovery earlier, toward pre-publication screening — but the CREC-based post-publication pipeline remains the backstop for everything that gets through regardless. The mark of a well-functioning system is not the absence of retractions; it is a transparent, standardised trail from complaint to notice that any reader can follow.

  • Recent History of Research Misconduct Scrutiny

    The recent history of attention to research misconduct runs from the 1986 Baltimore Case — which forced the creation of the US Office of Research Integrity (ORI) — through the 2000s rise of paper mills and image manipulation, to today’s concern that generative AI can fabricate entire papers, datasets, and images at a scale no journal can screen manually. Each phase added new oversight infrastructure without resolving the underlying incentive to publish at any cost.

    Research misconduct is defined by US federal policy as fabrication, falsification, or plagiarism (FFP) in proposing, performing, or reviewing research, or in reporting research results. This article traces how public and institutional attention to that problem has shifted — from a single congressional hearing in 1981 to a global infrastructure of retraction databases, publication-ethics bodies, and AI-detection tooling.

    The Baltimore Case: the event that built America’s oversight system

    The single most consequential episode in this history began in 1986, when postdoctoral researcher Margot O’Toole challenged the validity of data in an immunology paper published in Cell, co-authored by Nobel laureate David Baltimore and led by Thereza Imanishi-Kari. What started as a laboratory dispute became a decade-long federal investigation involving the NIH, congressional hearings chaired by Representative John Dingell, and forensic analysis of lab notebooks by the US Secret Service.

    Baltimore was never accused of fraud, but his public defence of Imanishi-Kari drew sustained criticism and cost him the presidency of Rockefeller University in 1991. Imanishi-Kari was formally cleared in 1996, when an appeals panel found her records sloppy but the evidence of intentional fabrication insufficient. By then the case had already reshaped US science policy.

    Congressional attention actually predates the Baltimore Case: Representative Albert Gore Jr held the first hearing on research misconduct in 1981, after roughly twelve cases surfaced at major US research centres between 1974 and 1981. It was the Baltimore Case’s decade of scrutiny, though, that cemented the need for a permanent federal body rather than ad hoc congressional inquiries.

    From ORI to COPE: institutionalising oversight (1992-2005)

    The US Office of Research Integrity (ORI) was formally established within the Department of Health and Human Services in May 1992, consolidating two predecessor offices created in 1989. The NIH Revitalization Act of 1993 made ORI independent and replaced “scientific misconduct” with “research misconduct” in federal policy, widening the definition beyond laboratory science.

    The Federal Research Misconduct Policy, published in the Federal Register on 6 December 2000, gave the US its first government-wide fabrication/falsification/plagiarism definition, still the reference ORI applies today. Internationally, the UK created the UK Research Integrity Office (UKRIO) in 2006, and the Committee on Publication Ethics (COPE) was founded by medical journal editors in 1997, giving publishers — not just funders — a formal adjudication mechanism.

    This period set the template still in use: institutions investigate first, an oversight body reviews the finding, and journals retract independently of any funder decision.

    Paper mills and image manipulation: the digital-era escalation

    Digital publishing made two categories of misconduct systemically visible. First, image manipulation: a 2016 screening study by microbiologist Elisabeth Bik and colleagues in mBio examined 20,621 papers across 40 journals and found 3.8% contained inappropriate image duplication, roughly half apparently deliberate. The 2005-2006 exposure of South Korean stem-cell researcher Woo Suk Hwang’s fabricated cloning results, which relied partly on manipulated photographs, pushed journals toward routine image screening for the first time.

    Second, paper mills: for-profit operations that manufacture fraudulent manuscripts, often with fabricated data or templated “tortured phrase” plagiarism, sold to researchers under career pressure to publish. Documented paper-mill output dates to the 2000s but accelerated sharply through the 2010s.

    The consequence is visible in the retraction record. 2023 was, per Nature’s coverage of Crossref and Retraction Watch data, a record year with over 10,000 retractions globally, a large share traced to paper-mill activity at a small number of publishers, notably Hindawi. That same year the Retraction Watch Database — previously subscription-only — was made freely available after Crossref took over its stewardship.

    Milestones in the recent history of attention to research misconduct
    Year Event Significance
    1981 First congressional hearing (Rep. Albert Gore Jr) Research misconduct becomes a public policy issue in the US
    1986-1996 Baltimore Case investigation and appeal Exposes inadequacy of ad hoc federal response; drives creation of ORI
    1992 Office of Research Integrity (ORI) established First permanent federal body dedicated to research misconduct
    1997 Committee on Publication Ethics (COPE) founded Gives journals a shared ethics framework independent of funders
    2000 Federal Research Misconduct Policy published Standardises the fabrication/falsification/plagiarism (FFP) definition
    2005-2006 Hwang Woo-suk stem-cell fraud exposed Establishes routine image-manipulation screening at journals
    2010s Paper mills scale up Fabricated manuscripts and fake peer review sold commercially
    2023 Record 10,000+ retractions; Retraction Watch Database opened via Crossref Retraction data becomes a shared, searchable public resource
    2023-present Generative AI text and image fabrication concerns Detection tools race to keep pace with synthetic fabrication at scale

    AI-era fabrication: what has genuinely changed

    Generative AI has not created a new category of misconduct — fabrication, falsification, and plagiarism remain the operative definitions — but it changes the economics of producing it. Large language models draft plausible manuscript text at near-zero marginal cost, and image generators can produce synthetic western blots or microscopy images that mimic genuine experimental output. Paper mills, already operating at scale before 2023, are widely reported to be early adopters of these tools.

    What is different is detection asymmetry: AI-generated text is often hard to distinguish from human writing using plagiarism tools built to match against a corpus of prior text, not to catch novel synthetic prose. Journals are responding with statistical-anomaly detection and image-forensics tooling, but this is explicitly reactive — the same pattern seen after the Baltimore Case and the Hwang case, where scrutiny follows scandal rather than anticipating it. The publish-or-perish incentive that produced the Baltimore Case in 1986 is the same incentive AI-assisted fabrication now threatens to industrialise further.

    Common questions on the history of research misconduct

    What are some examples of research misconduct?

    Under the US Federal Research Misconduct Policy, examples fall into three categories: fabrication (inventing data or results), falsification (manipulating research materials, equipment, or processes, or altering/omitting data), and plagiarism (appropriating another’s ideas, processes, results, or words without credit). Honest error and differences of scientific opinion are explicitly excluded.

    What group formed in 1992 to investigate scientific misconduct?

    The Office of Research Integrity (ORI) was established in May 1992 within the US Department of Health and Human Services, consolidating two predecessor offices — the Office of Scientific Integrity and the Office of Scientific Integrity Review — created in 1989. ORI remains the federal oversight body for misconduct in Public Health Service-funded research.

    What are the effects of research misconduct in today’s society?

    Research misconduct erodes trust between researchers, institutions, and funders, and it can distort the evidence base that clinical guidelines, policy decisions, and further research rely on. High-profile cases also fuel broader public scepticism about science, which institutions such as COPE and ORI argue makes rigorous, transparent investigation processes essential rather than optional.

    Implications for institutions, publishers, and funders

    For research administrators, the pattern is instructive: every major expansion of oversight infrastructure — ORI in 1992, COPE in 1997, routine image screening after 2006, the open Retraction Watch Database in 2023 — followed a scandal rather than preceding one. Institutions waiting for their own “Baltimore Case” before investing in integrity training and screening tools are, by this history, already behind.

    • Establish clear, documented processes for handling allegations before one arises, mirroring the institutional-first-response model ORI has required since 1989.
    • Adopt image-integrity and plagiarism screening as a routine pre-submission and pre-award step, not a post-publication response.
    • Track Retraction Watch Database entries relevant to your institution’s output as a standing due-diligence practice, now that the database is freely accessible via Crossref.
    • Treat AI-generated text and image detection as an evolving capability requiring periodic reassessment, not a one-off procurement decision.

    The throughline from 1986 to today is not that misconduct has become more common, but that the tools for producing it — and, gradually, for detecting it — have industrialised in step with the technology available in each era. The next inflection point in this history will likely be defined by whether detection capability can keep pace with generative AI, or whether institutional attention once again waits for the next public scandal to force the issue.

  • Stem Cell Research Scientific Misconduct Legacy

    Stem cell research scientific misconduct is best defined by two landmark cases: Hwang Woo-suk’s fabricated human cloning papers (South Korea, 2004-2006) and the STAP cell falsification scandal (Japan, 2014). Both involved fabricated data published in top journals, both were exposed through failed replication and image forensics, and both reshaped how institutions oversee stem cell research integrity today.

    Research misconduct is formally defined as fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting results. In stem cell science specifically, stem cell research scientific misconduct has produced two of the most consequential fraud cases in modern science, each triggering journal retractions, criminal or disciplinary proceedings, and lasting changes to how laboratories, journals, and funders verify extraordinary claims.

    What counts as stem cell research scientific misconduct?

    Stem cell research scientific misconduct covers fabricated data, falsified images, and unethical procurement of biological materials in studies involving embryonic, induced pluripotent, or somatic-cell-derived stem cell lines. The field is unusually exposed to this risk because of intense media attention, national prestige stakes, and the technical difficulty of independently verifying claims about pluripotency or successful cloning.

    Both cases examined here meet the formal definition applied by journals and integrity offices: invented results presented as genuine experimental findings, subsequently confirmed by institutional investigation and retracted from the scientific record.

    How did the Hwang Woo-suk cloning fraud unravel?

    Hwang Woo-suk, a veterinary scientist at Seoul National University, published two papers in Science in 2004 and 2005 claiming to have created the first cloned human embryonic stem cell lines through somatic cell nuclear transfer, including patient-matched lines for individuals with injuries or disease. The claims made Hwang a national figure in South Korea and were treated as a milestone toward personalised regenerative medicine.

    The case collapsed on two fronts simultaneously. First, journalists and whistleblowers within Hwang’s own laboratory raised concerns that junior female researchers had donated their own eggs for the experiments, a practice that breached informed-consent norms because of the coercive power dynamics involved. Second, a Seoul National University investigative panel examined the underlying data in December 2005 and January 2006 and found that none of the eleven claimed patient-specific stem cell lines existed; the single verified cell line was later shown to have arisen through parthenogenesis rather than cloning.

    • Science formally retracted both papers in January 2006.
    • Hwang was dismissed from his university post and indicted for fraud, embezzlement of research funds, and bioethical violations.
    • A South Korean court convicted him in 2009 and imposed a two-year suspended prison sentence, a verdict the South Korean Supreme Court upheld on appeal in 2014.

    What happened in the STAP cell scandal?

    In January 2014, RIKEN researcher Haruko Obokata and co-authors published two papers in Nature describing “stimulus-triggered acquisition of pluripotency” (STAP) — a claim that ordinary adult cells could be reprogrammed into a stem-cell-like state simply by exposing them to stress, such as a weak acid bath. The method promised a dramatically simpler alternative to existing induced pluripotent stem cell techniques.

    Independent laboratories worldwide were unable to replicate the results, and close scrutiny of the published figures revealed duplicated and manipulated images alongside plagiarised text from earlier work. RIKEN convened a formal investigation committee, which in April 2014 found Obokata guilty of falsification and fabrication. Nature retracted both papers in July 2014, and a subsequent verification experiment — conducted by Obokata herself under RIKEN supervision — failed to reproduce STAP cells by the end of that year, at which point she resigned.

    The human cost was severe. Obokata’s supervisor and senior co-author, RIKEN Center for Developmental Biology (CDB) deputy director Yoshiki Sasai, died by suicide in August 2014 amid the fallout. Waseda University revoked Obokata’s doctorate in 2015 after she failed to correct the thesis within a set deadline, and RIKEN CDB itself was dissolved and reorganised into the RIKEN Center for Biosystems Dynamics Research in 2018, partly in response to the reputational damage.

    How do the two cases compare?

    Despite occurring a decade apart and in different countries, the Hwang and STAP cases share a common failure pattern: extraordinary claims, inadequate internal verification before publication, and exposure driven by replication failure rather than routine peer review.

    Factor Hwang Woo-suk case STAP cell case
    Journal Science (2004, 2005) Nature (2014)
    Claimed method Cloned human embryonic stem cells via somatic cell nuclear transfer Pluripotency induced by external stress (acid bath)
    Detection trigger Whistleblower reports plus egg-donation ethics concerns Failed replication plus image duplication analysis
    Institutional finding Seoul National University panel, Dec 2005-Jan 2006 RIKEN investigation committee, April 2014
    Retraction date January 2006 July 2014
    Consequence for researcher 2009 conviction, two-year suspended sentence Resignation; doctorate revoked 2015

    What reforms followed these scandals?

    Both scandals functioned as forcing events for the wider research integrity infrastructure, well beyond the two institutions directly involved.

    • Image-forensics screening became standard practice at major journals after 2014, with publishers adopting software-assisted duplication and manipulation detection for every submitted figure, not just those flagged by reviewers.
    • The Committee on Publication Ethics (COPE) expanded its guidance on image manipulation and data fabrication, giving journal editors a shared, referenceable framework for handling suspected figure manipulation as research misconduct.
    • Institutional oversight of extraordinary claims tightened, with more stem cell laboratories requiring independent, blinded replication of headline results before submission.
    • Retraction Watch, founded in 2010, has since built a public database that made both cases — and thousands of subsequent retractions — searchable and citable as case-study evidence for research misconduct case studies used in training and policy work.
    • Egg-donation and biospecimen ethics protocols were tightened across stem cell research consent frameworks following direct scrutiny of the coercive donation practices in the Hwang case.

    Frequently asked questions

    What are the problems with stem cell research?

    Beyond the underlying ethical debate over embryo use, stem cell research carries elevated misconduct risk because pluripotency and cloning claims are technically hard to verify quickly, media and funding pressure reward speed over replication, and image-based evidence is easy to manipulate before independent scrutiny occurs.

    What is the controversy with stem cell research?

    The scientific controversy extends beyond embryo ethics to research integrity: the Hwang and STAP cases showed that landmark claims in prestigious journals could be entirely fabricated, undermining public trust and forcing funders and institutions to demand stronger pre-publication verification.

    Is stem cell research banned in the UK?

    No. The United Kingdom permits regulated human embryonic stem cell research under the Human Fertilisation and Embryology Authority framework, one of the more permissive regimes in Europe, though all work remains subject to licensing and ethical review distinct from the misconduct issues in the Hwang and STAP cases.

    What does this legacy mean for research integrity oversight?

    For research administrators, publishers, and funders, the enduring lesson of these two cases is structural, not personal: misconduct was caught by replication failure and whistleblowing, not by peer review at the point of publication. Institutional research integrity offices, journal editorial teams, and funder due-diligence processes now build in image screening, raw-data deposition requirements, and independent replication checkpoints specifically because peer review alone did not catch either fraud before publication.

    Two decades after Hwang and more than a decade after STAP, both cases remain the reference points cited whenever a stem cell claim looks too clean, too fast, or too convenient — a durable legacy for a field whose credibility depends on distinguishing genuine breakthroughs from fabricated ones.

  • Francesca Gino Research Misconduct Case Study

    The Francesca Gino research misconduct case is the 2021–2025 dispute in which Harvard Business School investigated, and ultimately dismissed, a tenured professor after concluding she had fabricated data in four published studies — a process that also produced a $25 million lawsuit, a Harvard countersuit, and one of the rare tenure revocations in the university’s modern history.

    Research misconduct, in the definition used by US federal policy and echoed by bodies such as the Committee on Publication Ethics (COPE), is the fabrication, falsification, or plagiarism of data in proposing, performing, or reviewing research. The Gino case is unusual not for the underlying allegation but for how visible the institutional machinery became: an 18-month internal inquiry, a 1,200-page report, a public unsealing order, and two overlapping lawsuits that together offer a rare, document-level view of how one major research university actually runs a misconduct investigation.

    What is the Francesca Gino research misconduct case?

    Francesca Gino was the Tandon Family Professor of Business Administration at Harvard Business School, where her research on honesty and ethical behaviour made her one of the most cited figures in behavioural science. Concerns about her data first surfaced around 2020, when a doctoral student’s replication attempt failed to reproduce a widely publicised Gino networking study. That failure led to a wider audit that eventually implicated four separate papers.

    Harvard’s internal investigation committee — three senior Harvard Business School faculty, assisted by an outside forensic firm — concluded that Gino had committed research misconduct intentionally, knowingly, or recklessly. The university placed her on unpaid administrative leave in June 2023 and, in May 2025, revoked her tenure and ended her employment before her two-year suspension had even run its course.

    How did Harvard’s misconduct investigation unfold?

    The Gino case shows a misconduct investigation moving through distinct, document-traceable stages rather than a single disciplinary event. Each stage generated its own record, several of which later became public through litigation.

    • 2020–2021: Doctoral candidate Zoé Ziani fails to replicate a Gino personal-networking study and raises concerns internally.
    • Autumn 2021: The Data Colada team — Uri Simonsohn, Leif Nelson, and Joseph Simmons — contacts Harvard Business School about anomalies in four Gino papers.
    • 2021–2023: Harvard conducts an internal investigation described by the HBS dean as an “18-month” process, producing a 1,200-page report under Case RI21-001.
    • June 2023: HBS places Gino on unpaid administrative leave; Data Colada simultaneously publishes its “Data Falsificada” blog series detailing the alleged anomalies.
    • August 2023: Gino files a $25 million lawsuit against Harvard, HBS Dean Srikant Datar, and the three Data Colada researchers, alleging defamation and gender discrimination.
    • March 2024: Judge Myong J. Joun orders the unsealing, with redactions, of Harvard’s 1,200-page investigation report.
    • September 2024: The court dismisses Gino’s defamation and privacy claims against both Harvard and the Data Colada defendants in full; breach-of-contract and gender-discrimination claims are allowed to proceed.
    • May 2025: The Harvard Corporation revokes Gino’s tenure and terminates her employment.
    • September 2025: Harvard sues Gino for defamation, alleging she submitted a falsified dataset to the university during the dispute.

    Notably, under US federal research-integrity rules, the Office of Research Integrity (ORI) only has jurisdiction over misconduct in Public Health Service-funded research. Much of Gino’s behavioural-science work fell outside that remit, meaning the entire investigation design — committee composition, evidentiary standard, and appeal rights — was governed solely by Harvard’s own internal policy rather than a codified federal or funder-mandated process.

    What evidence did investigators find in the retracted papers?

    Four papers sit at the centre of the case. All four have since been retracted, though the first was flagged for an unrelated data issue before the wider investigation began.

    Paper Journal Year published Retraction status
    “Signing at the beginning makes ethics salient…” (Shu, Mazar, Gino, Ariely, Bazerman) Proceedings of the National Academy of Sciences 2012 Retracted September 2021
    “Evil Genius? How Dishonesty Can Lead to Greater Creativity” (Gino, Wiltermuth) Psychological Science 2014 Retracted 2023
    “The Moral Virtue of Authenticity…” (Gino, Kouchaki, Galinsky) Psychological Science 2015 Retracted 2023
    “Why Connect? Moral Consequences of Networking…” (Gino, Kouchaki, Casciaro) Journal of Personality and Social Psychology 2020 Retracted 2023

    According to Harvard’s unsealed report, Gino offered investigators two explanations for the data irregularities: honest error by her or her research assistants, or tampering by a malicious third party with access to her files. The committee found neither explanation plausible, writing that her “repeated and strenuous argument” for a bad-actor scenario across four separate studies undermined the credibility of her broader testimony.

    A separate, self-organised accountability effort — the Many Co-Authors Project — later reviewed 56 papers naming Gino as involved in data collection. Its contributors reported that for roughly 60% of those papers, responding co-authors said they had never had access to the underlying raw data, a data-provenance gap that goes beyond the four papers formally retracted.

    What happened in the Gino v. Harvard litigation?

    Litigation is what made this a document-level case study rather than a private disciplinary matter. Gino’s August 2023 suit sought $25 million and alleged defamation, gender discrimination under Title IX, and breach of contract. Harvard’s decision to submit its full 1,200-page report as court evidence — and a subsequent judicial order to unseal it — meant the investigative record itself became a matter of public record, rather than remaining confidential under standard university misconduct procedure.

    Did Harvard sue Francesca Gino for defamation?

    Yes. In September 2025, Harvard filed its own defamation suit against Gino, alleging she submitted a falsified dataset to the university in an attempt to prove she had not committed data fraud. This followed her original 2023 defamation claim against Harvard, which a federal judge dismissed in September 2024.

    Does Francesca Gino still work at Harvard?

    No. The Harvard Corporation, the university’s top governing board, revoked Gino’s tenure and terminated her employment in May 2025, ending her unpaid suspension before it was due to expire. Harvard described tenure revocation as an extremely rare step not used at the institution for decades.

    Did Harvard revoke Francesca Gino’s tenure over falsifying data allegations?

    Yes. Harvard’s investigation committee, made up of three senior HBS faculty, concluded after an 18-month inquiry that Gino had committed research misconduct “intentionally, knowingly, or recklessly,” a finding that directly preceded the termination proceedings completed in 2025.

    What does the case reveal about institutional misconduct processes?

    For research administrators, the Gino case is less a story about one professor than a stress test of how an elite institution structures a misconduct inquiry when there is no external regulator compelling a specific procedure. Several implications stand out.

    • Investigation length is a real institutional risk. An 18-month internal inquiry, followed by two further years of litigation before a final personnel decision, shows how misconduct cases without a codified stage-gate process (unlike, for example, COPE’s published flowcharts) can extend for years and generate parallel legal exposure.
    • Confidentiality and public interest can collide. Harvard initially treated its 1,200-page report as confidential; a court order — not university policy — forced its unsealing. Institutions relying purely on internal confidentiality norms should anticipate that litigation can override them.
    • Peer self-auditing is emerging as a parallel accountability layer. The Many Co-Authors Project shows co-authors organising their own data-provenance review independently of the university process, filling a gap that formal institutional investigation did not cover at scale.
    • Whistleblower exposure has financial consequences. Data Colada’s team faced personal litigation risk for reporting anomalies, prompting outside researchers to crowdfund legal costs — a chilling-effect dynamic that institutional research-integrity policy rarely addresses directly.

    Frameworks such as the UK’s Concordat to Support Research Integrity and COPE’s core practices exist precisely to standardise the stages this case worked through ad hoc: initial concern, preliminary assessment, formal investigation, evidentiary report, and sanction. Institutions without an equivalent codified process should expect that, absent clear stage-gates, a misconduct case can default to years of litigation to resolve what a documented procedure might settle in months.

    The case remains open in part: Gino’s breach-of-contract and gender-discrimination claims against Harvard, and Harvard’s own defamation suit against Gino, were both still active as of late 2025. The eventual rulings will further shape how far US courts are willing to scrutinise a university’s internal misconduct-investigation process.

    For broader context on how institutions structure research-integrity roles and terminology, see CASRAI’s research administration resources and the CASRAI Dictionary.

  • Retraction Statement: 5 Elements COPE Requires

    A retraction statement must identify the article and its authors, state the specific reason for retraction, name who initiated it, record whether authors agree, and be permanently and bidirectionally linked to the original publication. These five elements come from the Committee on Publication Ethics (COPE) Retraction Guidelines and the NISO Recommended Practice for Communication of Retractions, Removals, and Expressions of Concern (CREC, RP-45-2024). A retraction statement is the formal notice, issued by a journal editor or publisher, that withdraws confidence in a previously published article’s findings while keeping the original text permanently accessible and marked as retracted.

    This guide is a drafting walkthrough, not a policy overview — it maps what COPE decides, what NISO’s CREC standard requires you to structure, and what EASE’s checklist helps you verify, into a single sequence editors and research-integrity offices can follow when a retraction notice actually has to go out.

    What must a retraction statement include?

    A compliant retraction statement combines a governance decision with a metadata obligation. COPE’s Retraction Guidelines set out when and why a retraction should happen; the NISO CREC Recommended Practice, published in June 2024, sets out how that decision must be communicated so it propagates reliably across databases, citation managers and search indexes. Combining both frameworks gives five required elements.

    # Element Source requirement
    1 Full identification of the retracted article (title, authors, DOI, citation) COPE Retraction Guidelines (2019)
    2 A specific, factual reason for retraction, distinguishing honest error from misconduct COPE Retraction Guidelines; NISO RP-45-2024
    3 Identification of who initiated the retraction (authors, editor, institution, publisher) COPE Retraction Guidelines
    4 Documented author agreement or disagreement with the decision COPE Retraction Guidelines
    5 Bidirectional, machine-readable linking between notice and original, with prompt free access NISO RP-45-2024 (CREC); COPE

    The original article is never deleted. Under COPE’s guidance it must remain online, clearly watermarked as retracted on every page of the PDF, with the retraction notice linked in both directions so readers encountering either document see the other. The EASE Standardised Retraction Form operationalises this as a checklist editors can complete before publication of the notice, reducing the inconsistency that COPE and NISO both identify as a persistent weakness in current practice.

    How do you document the reason for retraction?

    The reason section is where most retraction statements fail. A retraction statement must state, in unambiguous language, which specific data, figures or conclusions are affected and why — not merely that “errors were found.” Vague or reason-free notices deny authors the chance to explain honest mistakes and, per research cited in publisher guidance on this subject, remove the deterrent effect a clear misconduct finding is meant to provide.

    In practice, reasons cluster into recurring categories that function as informal reason codes across journals:

    • Honest error (calculation, methodological or reagent mistakes)
    • Data fabrication or falsification
    • Image or figure manipulation or duplication
    • Plagiarism or duplicate/overlapping publication
    • Ethical violations (consent, animal welfare, authorship disputes)
    • Irreproducibility discovered post-publication

    Plagiarism and data manipulation remain the most frequently cited categories in large-scale retraction analyses, and Nature reported that more than 10,000 research papers were retracted in 2023 alone — a record volume that intensified pressure on journals to standardise how reasons are recorded rather than merely disclosed. Where an institutional investigation produced the finding, the statement should attribute it directly to that body rather than restating it as the editor’s own conclusion.

    Who signs off on a retraction statement?

    Under COPE guidelines, the editor holds final authority to retract, but authors retain the right to have their agreement or disagreement recorded in the published notice. This is not a formality: a notice that silently presents unanimous agreement when one co-author disputed the decision misrepresents the record and can itself become a subject of complaint.

    Three sign-off outcomes are possible, and the statement should say plainly which applies:

    • Full agreement — all authors accept the retraction and its stated reason.
    • Partial agreement — some authors agree; named dissenting authors are recorded with their position.
    • Editor-initiated without author agreement — used when authors are unreachable, uncooperative, or contest findings the editor and, where applicable, the institution consider conclusive.

    Because contributor-level disputes often drive disagreement over sign-off, journals increasingly ask retracting authors to clarify individual contributions during the process — a task that structured contributor role taxonomies support. CASRAI originated the CRediT contributor role taxonomy in 2014; the standard is now stewarded by NISO as ANSI/NISO Z39.104-2022 and is widely used to attribute exactly whose CRediT contributor role is implicated when a retraction turns on data curation, analysis or investigation responsibilities rather than the paper as a whole. Research-integrity offices handling authorship disputes alongside a retraction should document this separately from the notice itself.

    How should a retraction be linked and communicated?

    NISO’s CREC Recommended Practice requires that retraction status be carried as structured, machine-readable metadata, not just prose in a PDF — so that discovery layers, citation managers and indexing services display the retraction consistently wherever the article appears, not only on the publisher’s own platform. This closes a long-documented gap: readers who encounter a retracted paper via a secondary database, preprint mirror or reference manager have often seen no retraction indicator at all.

    Practical requirements drawn from CREC and COPE together include:

    • Publishing the notice promptly and making it freely accessible, regardless of the original article’s access status
    • Applying a persistent, visible watermark to every page of the retracted PDF
    • Linking the notice and the original article bidirectionally via persistent identifiers (DOI)
    • Propagating retraction status to abstracting and indexing services and reference-linking systems
    • Retaining the retracted article permanently in the archive rather than removing it

    Retraction Watch’s database independently tracks whether these obligations are actually met, and its long-running “ideal retraction notice” analysis remains a useful benchmark precisely because so many notices still omit the reason, the initiator, or the sign-off status that COPE and NISO both specify.

    Common questions about retraction statements

    What is a retraction notice?

    A retraction notice is the published statement announcing that a journal article’s findings can no longer be relied upon. It is linked to the original article, states the reason, and remains permanently in the record — the article itself is marked as retracted, not deleted.

    What are the most common reasons for retraction?

    Large-scale analyses consistently rank plagiarism, data fabrication or falsification, and image or figure manipulation as the leading causes, followed by honest error and duplicate publication. Reason categories should always be stated explicitly rather than left generic.

    Do retracted studies still get cited?

    Yes. Published citation-tracking studies show retracted papers continue to be cited for years afterward, often because citing authors are unaware of the retraction. This is the core problem the NISO CREC standard’s machine-readable metadata requirement is designed to reduce.

    Can a retracted paper be republished?

    Under COPE’s position on this question, authors may republish reliable portions of a retracted work, provided they transparently notify the new journal’s editors of the prior retraction and its reason. Silent resubmission of retracted material is treated as a fresh ethics violation.

    What this means for editors and institutions

    Retraction volume is rising, not falling: Nature’s 2023 count of over 10,000 retractions was described by integrity researchers as “the tip of the iceberg,” reflecting better detection tools rather than worse research. That trajectory makes standardisation, not case-by-case drafting, the sustainable path for editorial offices and university research-integrity units alike.

    Editors who adopt the COPE-plus-CREC sequence — decide, document the reason, record sign-off, publish with persistent linked metadata — produce notices that hold up under later scrutiny from Retraction Watch, institutional auditors, and the authors themselves. Research-administration offices building or reviewing their own research-administration retraction workflow should treat the EASE form as the pre-publication check and NISO RP-45-2024 as the technical specification the published notice must satisfy.

  • Retraction Watch Database: Hiring Due Diligence

    The Retraction Watch Database (RWDB) lets research offices, tenure committees and funders check whether a candidate’s published papers carry a retraction, correction or expression of concern. Used properly — combined with author, affiliation, article-type or date-range search fields, cross-checked against ORI case summaries, and read for the stated reason rather than the bare fact of a hit — it becomes a genuine due-diligence tool rather than a source of false alarms.

    The Retraction Watch Database is a free, searchable index of scholarly retractions, corrections and expressions of concern, built by the Center for Scientific Integrity and distributed with Crossref. It is the largest curated source of retraction metadata available, but it indexes withdrawn papers, not people — why due diligence needs more than a name search.

    What Is the Retraction Watch Database, Exactly?

    RWDB is a structured dataset, not a blog archive: each entry records the original article, the notice, the stated reason, and the author/affiliation strings as printed on the paper. As of mid-2026 it logs more than 65,000 retraction entries. Crossref took on distribution in 2023, publishing the full CSV through a public repository rather than only the web form — the hosted interface at retractiondatabase.org suits one-off lookups; the download suits batch screening.

    Critically, RWDB does not aim for completeness on corrections and expressions of concern the way it does for retractions. Its own user guide states EOCs and corrections are entered mainly “as they relate to existing retractions, blog posts, or high-profile studies” — a clean result there is not evidence of a clean record.

    Search by author name first, narrow by affiliation, then confirm with PMID or DOI. Since 23 October 2024, RWDB has required every search to include at least one of: Article Type(s), an Original Paper date range, a Retraction/Notice date range, or a PMID/DOI — a blank author-only search no longer works, a change most existing search guidance predates.

    • Author field: try name variants and the wildcard (*), e.g. *doe*, since journals list authors inconsistently.
    • Affiliation field: free text only, matched against the original journal’s wording, not a normalised list.
    • Article Type / date range: now mandatory as a search anchor; pair a rough employment period with the author name.
    • PMID or DOI: the most precise route once a specific paper is identified.

    Each search returns a maximum of 50 rows on screen, with a banner showing the true total — worth noting when a prolific or common-named candidate returns more hits than the interface displays.

    What Counts as a Genuine Red Flag Versus a False Positive?

    A retraction hit is a prompt to investigate, not a finding of misconduct. RWDB’s reason-code taxonomy (Appendix B of the user guide) separates honest error, authorship disputes and duplicate publication from deliberate fabrication — only the latter is relevant to a fitness assessment.

    Signal Likely false positive Likely genuine concern
    Author role Middle/minor co-author, no data or analysis role First, corresponding, or last author
    Reason code Honest error, journal-initiated editorial correction Data fabrication, image manipulation, plagiarism
    Pattern Single isolated retraction across a long career Multiple retractions clustered in a short period
    Notice type Correction or expression of concern only Formal retraction with a stated integrity reason

    A 2025 study via Taylor & Francis, indexed on PubMed, found metadata discrepancies between RWDB, PubMed and Web of Science for the same retracted articles — reason to cross-reference a second source before treating any record as final. RWDB also standardises the author field to “Editorial Staff” on journal-initiated notices, never to be misread as identifying the candidate.

    Paper mills add a layer: outputs typically cluster by template, image reuse or tortured phrasing across unrelated author groups, a pattern the COPE–STM Paper Mills investigation has documented since 2022. A retracted paper matching paper-mill characteristics warrants closer scrutiny than an isolated retraction.

    How Does RWDB Compare With ORI Research Misconduct Case Summaries?

    RWDB and US Office of Research Integrity (ORI) case summaries answer different questions, and due diligence needs both. RWDB tells you whether a paper was withdrawn; ORI tells you whether a person was found, after federal investigation, to have committed misconduct — even where no retraction followed.

    Feature Retraction Watch Database ORI case summaries
    Unit of record A published article/notice A named individual with a misconduct finding
    Scope Global, all disciplines and publishers US Public Health Service-funded research only
    Trigger for entry A retraction, correction, or notable EOC is published A formal ORI investigation concludes with a finding
    Typical gap Misses misconduct with no resulting retraction Misses retractions outside PHS-funded, US-linked research

    Because ORI findings can precede, follow, or occur without a retraction, checking RWDB alone misses candidates sanctioned through supervision requirements or funding debarment whose flawed papers were never withdrawn. Hiring, tenure or funding decisions should run both checks, not treat either as a substitute.

    What Does a Due-Diligence Screening Workflow Look Like in Practice?

    1. Confirm identity anchors — collect name variants, ORCID iD, and known affiliations before searching.
    2. Run the RWDB author search with a date range or article-type anchor as required, using wildcards for name variants.
    3. Filter to retractions specifically — the default result mixes in corrections and expressions of concern, which are not comprehensively indexed.
    4. Read the reason code for every hit rather than counting hits; separate honest error from fabrication, plagiarism, or image manipulation.
    5. Check ORI case summaries for the same name, independently, to catch misconduct findings with no associated retraction.
    6. Cross-reference a second metadata source (PubMed, Web of Science) before any hit informs a decision.
    7. Document the process and allow a response — record which fields were searched and on what date, and give the candidate an opportunity to explain any substantive finding before it affects the outcome.

    Answer-First Q&A on Retraction Screening

    What is the Retraction Watch Database?

    The Retraction Watch Database is a free, searchable index of scholarly retractions, corrections and expressions of concern, distributed with Crossref. It records over 65,000 retraction entries with metadata on authors, journals, dates and stated reasons — but it indexes withdrawn papers, not verified findings against individuals.

    Do retracted studies still get cited?

    Yes. Citation-tracking studies confirm retracted papers continue to be cited after the retraction notice is published, often because citing authors are unaware of it. This is one reason due-diligence checks cannot rely on citation counts as a proxy for integrity.

    What is the purpose of Retraction Watch?

    Retraction Watch exists to track and report retractions as a window into how science self-corrects, publishing the underlying blog since 2010 and the structured database since 2018. Its purpose is transparency, not adjudicating misconduct — that sits with journals, institutions, and bodies such as ORI.

    How do you check for retractions on a specific paper or author?

    Search RWDB’s author or affiliation fields, or enter the paper’s PMID or DOI directly for the most precise match. Since October 2024 the search also requires an article-type or date-range anchor, so pair an author name with an approximate publication period.

    What Are the Implications for Research Offices and Funders?

    Institutions that skip a structured check within their research administration due-diligence process risk reputational and funding harm they could otherwise catch before an offer is made. Treating a single retraction hit as automatic disqualification risks penalising honest-error corrections with no integrity finding — both failure modes are avoidable with a documented, two-source workflow.

    Authorship transparency makes this more tractable: contributor-role frameworks such as CRediT — originated by CASRAI in 2014 and now stewarded by NISO as ANSI/NISO Z39.104-2022 — let a research office consult authorship and contribution records to see whether a flagged co-author actually held a data-generating or analytical role, rather than a minor one, sharpening the false-positive filter above.

    Where Is Misconduct Screening Heading Next?

    Expect due-diligence practice to keep converging on multi-source verification rather than any single registry. As paper-mill detection tooling matures and Crossref’s stewardship of RWDB deepens, the advantage will sit with research offices that build a repeatable, documented workflow now — spanning RWDB, ORI case summaries, and contributor-role verification — rather than an ad hoc name search at the point of hire.

  • Editorial Expression of Concern vs Retraction

    An editorial expression of concern is a notice a journal publishes to flag credible but unresolved doubts about a paper’s reliability, without retracting it. Editors use it instead of a retraction when the evidence is inconclusive, an institutional investigation is ongoing, or a fair resolution will take months rather than weeks.

    An editorial expression of concern (sometimes abbreviated EEoC) is defined by the Committee on Publication Ethics (COPE) as a journal notice about potential misconduct or unreliable findings, issued when the available evidence does not yet meet the threshold for a correction or a retraction. It sits deliberately between silence and withdrawal — a middle mechanism the scholarly record uses to signal risk without pre-judging guilt.

    What is an editorial expression of concern?

    An editorial expression of concern is a public, freely accessible notice — linked bidirectionally to the article it concerns — that tells readers a paper’s integrity is in question. Wikipedia’s entry on the topic describes it simply as “a notice issued by a publisher against a particular publication, warning that it may contain errors or be otherwise untrustworthy,” citing Morris, Barnas, LaFrenier and Reich’s Handbook of Journal Publishing (Cambridge University Press, 2013).

    Crucially, an expression of concern does not itself amend the scientific record. The original article remains published, unaltered, alongside the notice. It is a flag, not a verdict — and that distinction is precisely why journals reach for it before they reach for a retraction.

    Expression of concern vs retraction: what’s the difference?

    A retraction is a formal withdrawal: editors have concluded, on clear grounds, that a paper’s findings are unreliable because of fabrication, falsification, plagiarism, an invalidating honest error, or an unresolved ethical breach. COPE’s Retraction Guidelines (Version 3, 2025) set out the timing, content and evidentiary bar for that step. A retraction changes how the article is labelled in perpetuity; it does not usually remove the text, but it marks it as withdrawn from the reliable literature.

    An expression of concern makes no such finding. It is an interim or, occasionally, a terminal notice used precisely because the evidence does not yet support — or may never support — a definitive retraction decision. The International Committee of Medical Journal Editors (ICMJE), in its December 2019 recommendations on “Scientific Misconduct, Expressions of Concern, and Retraction,” acknowledges that a publisher may issue an expression of concern while a misconduct investigation is ongoing, and pending its outcome, rather than waiting in silence or retracting prematurely.

    Feature Expression of concern Retraction
    Evidence threshold Inconclusive or investigation ongoing Clear grounds established
    Effect on the article Article stands, flagged with a linked notice Article marked withdrawn from the record
    Typical trigger Credible allegation, pending institutional inquiry Confirmed fabrication, falsification, plagiarism or invalidating error
    Finality Interim — or occasionally the final outcome if no further update is expected Final

    When does COPE say editors should issue one?

    COPE’s dedicated guideline on expressions of concern gives editors concrete criteria. It states that editors should consider issuing an expression of concern if significant and credible concerns have been raised but the evidence is unclear as to whether the work, or parts of it, are potentially unreliable — whether from error, incorrect analysis, or research-integrity concerns affecting the main findings.

    Other qualifying scenarios include:

    • An institutional, funding, or other formal oversight investigation is ongoing and may lead to corrections based on the work’s reliability.
    • Authors have been asked for additional information to address concerns, and it is not immediately available.
    • There is an unresolved breach of journal or publisher policy — for example, data that were available at publication but later withheld.
    • A resolution is not expected for some time, typically several months.

    COPE is equally clear about when an expression of concern is not appropriate: if the editor can quickly reach a decision, if resolution is only weeks away, if the main findings remain reliable, or if the sole concern relates to authorship rather than the underlying findings. Publishing a notice that will be superseded within weeks risks confusing readers rather than informing them.

    Corrigendum vs erratum vs expression of concern: where each notice fits

    Expressions of concern sit alongside — but are distinct from — the more routine correction notices journals issue. In standard publishing practice, a corrigendum is a correction initiated by the authors themselves to fix an error they introduced (a wrong affiliation, a miscalculated value, an omitted co-author), while an erratum corrects a mistake introduced by the publisher during production or typesetting — the classic corrigendum vs erratum distinction. Neither implies a reliability concern about the underlying findings; both simply amend the published record.

    The National Information Standards Organization’s 2024 recommended practice, NISO RP-45-2024, “Communication of Retractions, Removals, and Expressions of Concern (CREC),” formalises how publishers and indexers should structure and disseminate these various post-publication notices so that the scholarly record — and the systems that index it — stay consistent across platforms.

    Notice type Who initiates it What it signals Effect on the record
    Corrigendum Authors Author-side error in an otherwise sound paper Text amended; original findings stand
    Erratum Publisher Production or typesetting error Text amended; original findings stand
    Expression of concern Editors/publisher Credible, unresolved doubt about reliability Article stands, flagged pending outcome
    Retraction Editors/publisher Confirmed unreliability or misconduct Article marked withdrawn

    Related questionable research practices — undisclosed image manipulation, salami-slicing, or selective reporting — often surface first through post-publication scrutiny on platforms such as PubPeer, which can prompt an editor to move from silence toward one of these four notice types.

    Frequently asked questions

    What is an editorial expression of concern?

    An editorial expression of concern is a notice issued by editors or a publisher to draw attention to potential problems in a published paper, without itself constituting a retraction or a correction. It flags unresolved doubt while the article remains part of the published record.

    What is an example of when an expression of concern applies?

    COPE gives the example of an editor receiving inconclusive evidence of misconduct, or learning that findings appear unreliable but the authors’ institution declines to investigate. In both cases, the concern is credible but not yet provable, so a flag — not a withdrawal — is the appropriate response.

    What is the difference between an expression of concern and a retraction?

    An expression of concern is a provisional flag issued when evidence is incomplete; a retraction is a final, formal withdrawal issued once editors have established clear grounds — fabrication, falsification, plagiarism, or an invalidating error. One pauses judgement; the other delivers it.

    Is Retraction Watch a credible source for tracking these notices?

    Retraction Watch is widely cited by researchers, journalists and integrity officers as a tracking resource and maintains a large public database of retractions. It is a secondary aggregator, not a standards body — for authoritative process guidance, COPE, ICMJE and NISO remain the primary reference sources.

    Implications for institutions, publishers and researchers

    For research administrators and institutional integrity officers, an expression of concern on a faculty member’s paper is not proof of misconduct — but it is a signal that warrants tracking, particularly where funding, promotion, or REF-style assessment exercises depend on the work’s standing. Institutions should distinguish, in their own case-management records, between papers carrying a corrigendum or erratum (routine) and those carrying an expression of concern (an active, unresolved integrity question).

    For publishers and journal editors, COPE’s criteria function as a due-process safeguard: they prevent both premature retraction, which can unfairly damage careers, and prolonged silence, which leaves readers citing potentially unreliable findings unwarned. NISO RP-45-2024’s structured communication requirements push this further, aiming to make expressions of concern discoverable wherever an article is indexed, not just on the publisher’s own site.

    As post-publication scrutiny — via PubPeer, institutional audits, and journal-side data checks — continues to intensify, expressions of concern are likely to become a more visible, more standardised fixture of the published record, sitting permanently between the routine correction and the definitive retraction.